471 related articles for article (PubMed ID: 28435037)
1. Therapeutic strategies in Sickle Cell Anemia: The past present and future.
Fernandes Q
Life Sci; 2017 Jun; 178():100-108. PubMed ID: 28435037
[TBL] [Abstract][Full Text] [Related]
2. Exercise limitation, exercise testing and exercise recommendations in sickle cell anemia.
Connes P; Machado R; Hue O; Reid H
Clin Hemorheol Microcirc; 2011; 49(1-4):151-63. PubMed ID: 22214686
[TBL] [Abstract][Full Text] [Related]
3. Sickle cell disease pathophysiology.
Noguchi CT; Schechter AN; Rodgers GP
Baillieres Clin Haematol; 1993 Mar; 6(1):57-91. PubMed ID: 8353318
[TBL] [Abstract][Full Text] [Related]
4. Pathophysiological-based approaches to treatment of sickle cell disease.
Steinberg MH; Brugnara C
Annu Rev Med; 2003; 54():89-112. PubMed ID: 12359829
[TBL] [Abstract][Full Text] [Related]
5. Sickle Cell Hemoglobin.
Mandal AK; Mitra A; Das R
Subcell Biochem; 2020; 94():297-322. PubMed ID: 32189305
[TBL] [Abstract][Full Text] [Related]
6. Sickle cell disease: a review and update of current therapy.
Lawrenz DR
J Oral Maxillofac Surg; 1999 Feb; 57(2):171-8. PubMed ID: 9973126
[No Abstract] [Full Text] [Related]
7. Transfusion therapy in congenital hemolytic anemias.
Sharon BI
Hematol Oncol Clin North Am; 1994 Dec; 8(6):1053-86. PubMed ID: 7860437
[TBL] [Abstract][Full Text] [Related]
8. Principles of blood transfusion in sickle cell anemia.
Al-Saeed HH; Al-Salem AH
Saudi Med J; 2002 Dec; 23(12):1443-8. PubMed ID: 12518188
[TBL] [Abstract][Full Text] [Related]
9. Chronic transfusion practice for children with sickle cell anaemia and stroke.
Aygun B; McMurray MA; Schultz WH; Kwiatkowski JL; Hilliard L; Alvarez O; Heeney M; Kalinyak K; Lee MT; Miller S; Helms RW; Ware RE;
Br J Haematol; 2009 May; 145(4):524-8. PubMed ID: 19344396
[TBL] [Abstract][Full Text] [Related]
10. Not all red cells sickle the same: Contributions of the reticulocyte to disease pathology in sickle cell anemia.
Carden MA; Fasano RM; Meier ER
Blood Rev; 2020 Mar; 40():100637. PubMed ID: 31735458
[TBL] [Abstract][Full Text] [Related]
11. Overview of pathophysiology and rationale for treatment of sickle cell anemia.
Rodgers GP
Semin Hematol; 1997 Jul; 34(3 Suppl 3):2-7. PubMed ID: 9317195
[TBL] [Abstract][Full Text] [Related]
12. Established and experimental treatments for sickle cell disease.
De Franceschi L; Corrocher R
Haematologica; 2004 Mar; 89(3):348-56. PubMed ID: 15020275
[TBL] [Abstract][Full Text] [Related]
13. Current and future therapies of sickle cell anemia: an historical perspective.
Gladwin MT
Hematology Am Soc Hematol Educ Program; 2008; ():176. PubMed ID: 19074077
[No Abstract] [Full Text] [Related]
14. Chronic transfusion regimens in sickle cell disease.
Milner PF
Prog Clin Biol Res; 1982; 98():97-107. PubMed ID: 7146025
[No Abstract] [Full Text] [Related]
15. Effects of total hemoglobin and hemoglobin S concentration on cerebral blood flow during transfusion therapy to prevent stroke in sickle cell disease.
Hurlet-Jensen AM; Prohovnik I; Pavlakis SG; Piomelli S
Stroke; 1994 Aug; 25(8):1688-92. PubMed ID: 8042222
[TBL] [Abstract][Full Text] [Related]
16. [Physiopathological basis of sickle cell disease, management and current therapeutics].
Galacteros F
Bull Soc Pathol Exot; 2001 May; 94(2):77-9. PubMed ID: 11475031
[TBL] [Abstract][Full Text] [Related]
17. The role of transfusion therapy in the treatment of sickle cell disease.
Miller C
J Intraven Nurs; 1994; 17(2):70-3. PubMed ID: 8064491
[TBL] [Abstract][Full Text] [Related]
18. Investigational drugs in sickle cell anemia.
Kotiah SD; Ballas SK
Expert Opin Investig Drugs; 2009 Dec; 18(12):1817-28. PubMed ID: 19780709
[TBL] [Abstract][Full Text] [Related]
19. Promising therapies in sickle cell disease.
Raghupathy R; Billett HH
Cardiovasc Hematol Disord Drug Targets; 2009 Mar; 9(1):1-8. PubMed ID: 19275572
[TBL] [Abstract][Full Text] [Related]
20. Blood transfusion in sickle cell disease.
Marouf R
Hemoglobin; 2011; 35(5-6):495-502. PubMed ID: 21981466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
